Down-regulation of β-adrenergic receptors on mononuclear leukocytes induced by dobutamine treatment in patients with congestive heart failure

J. K. Teng, C. M. Kwan, L. J. Lin, L. M. Tsai, J. T. Cheng, W. C. Chang, J. H. Chen

研究成果: 雜誌貢獻文章同行評審

9 引文 斯高帕斯(Scopus)

摘要

(±)-Dobutamine is a positive inotropic drug usually used to improve ventricular function in patients with congestive heart failure (CHF). However, it has been found that haemodynamic responses to dobutamine become blunted during continuous treatment. In this study we determined the time-dependent changes of β-adrenergic receptors in CHF patients treated with dobutamine. Seven CHF patients received a continuous intravenous infusion of dobutamine (5 μg . kg-1 . min-1) for 96 h. Blood samples were obtained before and every 24 h after starting the therapy. The density of β-adrenergic receptors on mononuclear leukocytes and the plasma concentrations of norepinephrine and epinephrine were determined. During dobutamine treatment the receptor density (fmol . mg-1, mean ± SEM) gradually decreased from 42.8 ± 4.4 (baseline) to 31.4 ± 3.3 (P

原文英語
頁(從 - 到)1349-1353
頁數5
期刊European Heart Journal
14
發行號10
出版狀態已發佈 - 1993
對外發佈

ASJC Scopus subject areas

  • 心臟病學與心血管醫學
  • 統計、概率和不確定性
  • 應用數學
  • 生理學(醫學)
  • 生理學

指紋

深入研究「Down-regulation of β-adrenergic receptors on mononuclear leukocytes induced by dobutamine treatment in patients with congestive heart failure」主題。共同形成了獨特的指紋。

引用此